Zhimou Cai is an expert in Oncology at Sun Yat-sen University (China). Zhimou Cai has authored 12 publications, the most recent in 2025, and is an investigator in 1 clinical trial. SLR score: 60 (community average: 125). How the SLR is computed.

LeadR Profile

Zhimou Cai Sun Yat-sen University China
60 ScienceLeadR Reputation 60
Network Map

Oncology

Subspecialties:

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2026 - 2026

Source: PubMed

Sun Yat-sen University

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 12

Citations

Citations: 111 1st author: 5 Last author: 0 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Single-Cell and Bulk RNA Sequencing Reveal Tumor Cell Characteristics and Communication Features of Primary and Lymphatic Metastatic Hypopharyngeal Squamous Cell Carcinoma.
PMID 40395022 — cells, genes, carcinoma, squamous cell, communication, neoplasms, neoplasm metastasis, therapeutics, tumor microenvironment, prognosis, rna
Head Neck20250
CD271 cancer stem cells regulate macrophage polarization in head and neck squamous cell carcinoma.
PMID 39854870 — cells, growth, microscopy, electron, scanning transmission, carcinoma, squamous cell, macrophages, neoplasms, stem cells, squamous cell carcinoma of head and neck, therapeutics, prognosis
Oral Oncol20250
Nomogram Prediction of Response to Neoadjuvant Chemotherapy Plus Pembrolizumab in Locally Advanced Hypopharyngeal Squamous Cell Carcinoma.
PMID 39921555 — cells, blood, carcinoma, squamous cell, nomograms, drug therapy, otorhinolaryngologic surgical procedures, therapeutics, chemotherapy
J Otolaryngol Head Neck Surg20250
Tenecteplase Thrombolysis for Stroke up to 24 Hours After Onset With Perfusion Imaging Selection: The CHABLIS-T II Randomized Clinical Trial.
PMID 39744861 — hemorrhage, ischemic stroke, stroke, intracranial hemorrhages, thrombolytic therapy, cerebrovascular circulation, reperfusion, cerebrovascular disorders, tenecteplase, therapeutics, random allocation, perfusion imaging
Stroke202531
Single-cell RNA sequencing reveals pro-invasive cancer-associated fibroblasts in hypopharyngeal squamous cell carcinoma.
PMID 37853464 — cells, carcinoma, squamous cell, neoplasms, cell communication, cancer-associated fibroblasts, fibroblasts, therapeutics, prognosis, rna
Cell Commun Signal202313

Clinical Studies 1

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 2 1

By status:

Completed 1

By type:

Interventional 1

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 0
multicentric5to9 0
multicentricup10 0

Main Topics

LeadR Networks

Main global connection map